The role of antioxidants in the management of hearing loss has generated considerable interest over the past several years. Research efforts in this field have yielded many new insights into the molecular and cellular nature of several types of hearing impairment, including age-related, noiseinduced, and drug-induced hearing loss. The objective of this paper is to highlight some of the important studies published over the past several years that have further contributed to our understanding of the mechanism of antioxidants in attenuating hearing loss.
Introduction
The role of antioxidants in attenuating hearing loss has been the subject of much interest, scrutiny, criticism, and controversy over the past several years. The plethora of research studies in this field attests to the impact that antioxidants have had on scientific thought and our society overall. Over the past year, several studies have been published that largely support the role of antioxidants in reversing or attenuating the deleterious effects of reactive oxygen species (ROS). This trend has been noted in earlier studies and has been the impetus for continuing research efforts in this field.
An increase in reactive oxygen species (ROS) production is postulated to play an important role in age-related, noise-induced, and drug-induced hearing loss. ROS contain an unpaired number of electrons, rendering them chemically reactive and toxic to cellular and subcellular structures. ROS have been implicated in the pathophysiologic processes of more than 100 medical conditions [1] . They are generated in vivo as a byproduct of mitochondrial respiration, and are also produced via autooxidation of chemical and biological molecules. ROS are also environmental contaminants and can be formed from ionizing and ultraviolet radiation. The most common ROS are superoxide anion (O 2 À ), hydroxyl radical (OH À ), hypochlorite (OCl À ), and nitric oxide (NO À ). ROS are converted to nonreactive molecules by endogenous cellular enzymes, such as copper/zinc superoxide dismutase (SOD1), manganese superoxide dismutase (SOD2), catalase, and peroxidase. Additionally, the administration of exogenous antioxidants, such as a-lipoic acid, acetyl-L-carnitine (ALCAR), N-acetylcysteine (NAC), vitamins E and C, and phytochemicals, also results in scavenging of ROS. The medical literature has overwhelmingly supported the protective effects of antioxidants and ROS scavengers on age-related, noise-induced, and drug-induced hearing loss. Several studies and review articles from the senior author's laboratory have helped to elucidate some of the molecular events leading to these various types of acquired hearing loss, as well as to identify specific antioxidants that have significant beneficial effects on hearing loss [2-9].
Antioxidants in age-related hearing loss
Presbyacusis is the progressive, high frequency, sensorineural hearing loss that occurs with advancing age. The accumulation of ROS is strongly implicated in the aging process and is regarded as an important deleterious event in the genesis of presbyacusis [10] . The persistent interaction of ROS with cellular and subcellular (i.e. mitochondrial) structures ultimately leads to tissue damage and cell death. The National Institutes of Health has estimated that approximately 30-35% of adults between the ages of 65 and 75 years have some degree of hearing loss [11] . Furthermore, approximately 40-50% of people aged 75 years and older have hearing loss that can impair communication.
Numerous hypotheses have been advocated to explain the mechanisms of the aging process. These can be broadly grouped into two categories: those that implicate deterministic, or 'programmed', alterations in gene expression or gene structure; and those that implicate a variety of stochastic or 'random' alterations in the structure and function of macromolecules, cells and organ systems. The corresponding author's laboratory and others have also provided compelling evidence that diseases associated with the aging process result from the accumulation of ROS. ROS directly damages subcellular structures, such as mitochondrial DNA (mtDNA), creating deletions and mutations, subsequently producing bioenergetically deficient cells. This cascade of events leads to senescence, cell death, and hearing loss. Senescence is the progressive accumulation of metabolic and physiologic derangements, which increases susceptibility to disease. Several theories have been proposed to explain the phenomenon of senescence. The most convincing theories are the telomerase theory of aging, the dysdifferentiation hypothesis of aging, and the membrane hypothesis of aging (MHA), also referred to as the mitochondrial clock theory of aging.
In the telomerase theory of aging, a reduction in telomere length occurs over time. The end of a chromosome is composed of a structure called the telosome, the tip of which is the telomere. Reduction in the length of the telomere and alterations in its chromatin assembly may account for the instability that occurs during senescence [12] . It has been suggested that the balance between telomere shortening and telomerase activity may underlie various cellular aging processes.
In the dysdifferentiation theory, aging occurs on a continuum of programmed differentiation leading to either a cessation of normal gene activity or a systematic activation of genes whose effects are deleterious to cellular function.
The MHA suggests that aging is related to a decreased effectiveness of cellular protective and reparative mechanisms, yielding biochemical and metabolic errors that progressively accumulate, resulting in eventual cell death [13] . Furthermore, the MHA postulates that cellular senescence is attributable to the cross-linking action of ROS or radicals within the cellular membrane.
Additionally, these ROS result in lipid peroxidation, polysaccharide depolymerization, nucleic acid disruption, and oxidation of sulfhydryl groups, leading to enzyme inactivation [14] . Hence, the MHA suggests that ROS induced cell membrane structural damage is the primary mediating event in cellular aging [15, 16] . It is plausible that various aspects of these theories occur in concert and serve to better explain the aging process. For example, ROS generation leads to genetic and cellular alterations resulting in cellular dysfunction, and consequently to senescence.
Significant progress has been made to identify the molecular mechanisms of age-related hearing loss. This in turn has led to research on methods of mitigating the adverse effects on the auditory system. Understanding of the relevant mechanisms of aging provides a potential roadmap for interventional therapeutic strategies to counteract the processes of aging. There is increasing evidence suggesting that ROS have a putative role in the damage associated with cochlear ischemia, noise trauma, aging, presbyacusis, and ototoxicity.
The focus of the corresponding author's laboratory is to elucidate the mechanisms of aging, specifically the role that ROS plays in this process. The aging process partly occurs due to oxidative stress, resulting in increased mitochondrial DNA mutations, and a concomitant reduction in mitochondrial function. These changes ultimately lead to cellular and subcellular dysfunction, which likely manifests in the inner ear milieu as a significant decrease in auditory sensitivity. The generation of these ROS is partly responsible for the reduction in the mitochondrial membrane potential and the loss of cochlear hair cells, with an attendant increase in the auditory threshold. These deleterious effects of aging can be slowed and in some situations even reversed through strategies that affect the bioenergetic properties of cells. In 2000, a study published from our laboratory demonstrated significant protective effect in auditory thresholds in subjects either treated with specific antioxidants or caloric restriction. The results of this 5-year series of experiments represented the first prospective randomized trial designed to investigate the effect of antioxidants, nutritional supplementation and dietary restriction on hearing loss specifically and aging in general. This study and earlier ones were the first to propose that the mechanism involving the generation of ROS and resultant damage to mitochondria may be responsible for presbyacusis [2, 3, 5] . The findings from these experiments demonstrated that dietary restriction and specific nutrient supplementation reduce the progression of age-related hearing loss [5] . This beneficial effect was thought to likely represent a reduction in oxidative stress through antioxidant therapy.
In the past year, several studies have corroborated the evidence accumulated from previous years and those obtained from our laboratory. In a recent article by de Rivera et al. [17 ] , the effect of blueberry phytochemical, an antioxidant, on the speed of temporal processing in primary auditory cortex aged rats was investigated. This study showed that the frequency modulated sweep in the aged rats that had been fed a blueberry-enriched diet for 8 weeks was faster than aged rats that had been feed corn pellet or normal rat chow pellets. Furthermore, the aged rats that were fed the blueberry-enriched diet had a faster frequency modulated sweep than young rats. This was the first study to investigate the effects of blueberry phytochemicals on sensory processing. Le and Keithley [18 ] investigated the effects of an antioxidant-rich diet in beagle dogs on age-related cochlear structural changes. They found that the dogs that were fed a diet rich in vitamin E, L-carnitine, DL-a-lipoic acid, and vitamin C in the last 3 years of their lives exhibited a greater neuronal density in the apical turn of the spiral ganglion versus an age-matched control group. When these antioxidant-enriched dogs were compared with a younger group of dogs, there was no difference in the neuronal density between the two. In addition, when comparing the stria vascularis thickness in the antioxidant-enriched aged dogs versus the age-matched control group, there was a larger amount of neuronal degeneration at the basal and apical ends of the cochlea in the age-matched control group. The stria vascularis is rich in mitochondria. Exposure to ROS results in degradation of the mitochondria, thus contributing to age-related ultrastructural changes in the cochlea. Auditory thresholds were not obtained during this study, however, thus conclusions about resultant hearing differences would be speculative. Nevertheless, these types of studies offer significant promise for the treatment of presbyacusis. Research efforts need to be directed to performing prospective randomized studies in humans to more convincingly demonstrate the beneficial and powerful effect of antioxidants on age-related hearing loss. These studies, however, provide encouraging evidence that antioxidants may slow down, reverse or improve the process of agerelated hearing loss. The research on antioxidants and their role in attenuating or reversing the effects of agerelated hearing loss is compelling and overwhelmingly positive. Our contention is a diet rich in certain specific antioxidants should be offered to all patients experiencing age-related hearing loss.
Antioxidants in noise-induced hearing loss
Noise-induced hearing loss (NIHL) is a type of highfrequency sensorineural hearing loss, often with a classic notch at 4000 Hz. It is a preventable cause of hearing loss caused by excessive exposure to either acute or chronic acoustic trauma. Though NIHL is usually associated with occupational exposure such as in the automotive industry and the military, it also occurs as a result of recreational pursuit exposure, such as using personal listening devices. Acoustic trauma can be tremendous enough to cause mechanical disruption of the cochlea resulting in immediate, permanent hearing loss. Most clinical scenarios, however, are due to a gradual hearing loss, which results from cumulative oxidative metabolic stress and damage. Considerable research [19 ] has been aimed at investigating antioxidants to treat or prevent the onset or progression of NIHL. The senior author has studied the effects of resveratrol, a phytoalexin and nutritional supplement found in the skin of red grapes, on acoustic trauma. In a study published in 2003, resveratrol supplementation was noted to reduce threshold shifts in young rats exposed to significant acoustic trauma (105 dB over a range of 4500-9000 Hz, for 24 h) compared to a similar group of rats supplemented only with normal saline [20] .
With massive noise stimulation, an excessive amount of glutamate, a neurotransmitter at the junction of the inner hair cells and afferent neuron in the peripheral auditory system, is released resulting in ionic influx and massive entry of water and extracellular calcium into the afferent neurons, causing cell death and noise induced hearing loss [21, 22] . Duan et al. [23 ] investigated the protective effect of caroverine, an antioxidant and an antagonist of two glutamate receptors, against acoustic trauma in rats. The rats were divided into two groups, one that was pretreated with administration of subcutaneous caroverine for 72 h, and a second group given subcutaneous saline. After 48 h, each group was exposed to impulse noise at 160 dB. The study revealed that prior to impulse noise insult, subcutaneously administered caroverine decreased impulse noise-induced hearing loss in rats. An antioxidant that has been extensively studied in relation to NIHL is NAC. NAC stimulates the production of the major cellular antioxidant, glutathione in hair cells [24] , acts as a free radical scavenger, and inhibits cell death pathway enzymes [25] [26] [27] [28] . Coleman et al. [29 ] investigated the protective effect of NAC 1, 4, and 12 h after NIHL in chinchillas. The animals were divided into three groups: those administered a saline control, those supplemented with NAC, and those given ALCAR (a mitochondrial bio-energy maintenance and integrity compound). The animals were first exposed to 6 h of 105 dB sound-pressure level octave band noise centered at 4000 Hz. One hour after noise exposure, the greatest decrease in hearing loss was noted in the NAC and ALCAR supplemented groups. There was no improvement in hearing, however, when NAC and ALCAR were administrated 12 h after noise exposure.
To determine the effect of NAC on NIHL in humans, as the other studies described herein have been in animals, Kramer et al. [30 ] performed a randomized, double-blinded, placebo-controlled study. Distortion product otoacoustic emission (DPOAE) measurements were performed on the participants before and 2 h after exposure to live music at a nightclub. The participants were either given a 900 mg tablet of NAC or a placebo 30 min before noise exposure. No statistical significance was seen in either group in DPOAE measurements.
Though the study did not show a protective benefit of NAC in humans, it is still believed that taking NAC before noise exposure is beneficial. A randomized, double-blinded, placebo controlled study in humans that investigated the effect of NAC at different doses and varying time schedules still needs to be performed to demonstrate a statistically significant protective effect of NAC in NIHL.
Antioxidants in drug-induced hearing loss
Platinum based chemotherapeutic agents and aminoglycosides have been shown to be ototoxic, often resulting in bilateral, symmetric sensorineural hearing loss. Of the platinum based agents, cisplatin is more commonly and classically associated with ototoxicity, though carboplatin has also been shown to be ototoxic. Coling et al. [31 ] identified three of the five cochlear proteins that are upregulated and four of the 17 cochlear proteins that are downregulated with cisplatin treatment causing ototoxicity. Cisplatin administration results in ROS generation, [32] causing an increase in lipid peroxidation of cell membranes, which results in outer hair cell damage [33] . The effects of cisplatin ototoxicity also manifest in the organ of Corti, spiral ganglion cells, and the stria vascularis. The damage that is caused to the organ of Corti is permanent, but the damage to the stria vascularis is transient. Similarly, aminoglycosides directly damage the outer hair cell membrane. Though the mechanism of action is not completely understood, ROS production has been suggested as a causative factor [34] [35] [36] .
Sodium thiosulphate (STS), a reactive thiol compound, has been investigated extensively and found to reduce ototoxicity caused by cisplatin in mice and guinea pigs [37] [38] . STS acts by binding and inactivating the platinum-containing DNA alkylating agents, and by acting as a free radical scavenger. This results in otoprotection from cisplatin and carboplatin [39 ] . It has been shown, however, that co-administration of sodium thiosulphate and cisplatin can reduce the antitumor effects of cisplatin [37] . Neuwelt et al. [39 ] investigated carboplatin and ototoxicity in children. The objective of their study was to determine whether delaying STS administration 4 h after carboplatin would be protective in 12 children treated for a brain tumor. Though the data were not statistically significant, owing to a small sample size, it was determined that high dose STS was safe in children. A natural antioxidant that has been found to resolve inner ear symptoms is the ethanol extract of the steamed roots of Rehmannia glutinosa Liboschitz (SRG) [40] . Yu et al. [41 ] investigated the dose of SRG that would prevent cisplatin ototoxicity. HEI-OCI auditory cells were pretreated with 0, 5, 10, 50 and 100 mg/ml of SRG for 1 h, after which cisplatin was added to each cell culture. SRG prevented cisplatin-induced lipid peroxidation in a dose-dependent manner. In addition, it was found that SRG acts as a free radical scavenger by removing ROS, more specifically, hydrogen peroxide, hydroxyl radical, and 1,1-dipheny-2-picrylhydrazyl (DPPH) radicals. To determine the protective effects of sodium thiosulphate on gentamicin-induced hearing loss, Hochman et al. [42 ] investigated the effects on C57 mice. There were four groups: a group receiving intraperitoneal injection of only gentamicin, a group receiving injection of only sodium thiosulphate, a group receiving injection of both of gentamicin and sodium thiosulphate, and a group injected with normal saline. Auditory brainstem response (ABR) thresholds were recorded at initiation of the study and then on day 35. Though the results showed a promising trend towards a protective effect of sodium thiosulphate, it was not statistically significant.
These studies suggest that antioxidants can protect against drug-induced hearing loss, though further studies are needed to clearly advocate the routine prophylactic and therapeutic use of antioxidants in drug-induced hearing loss. The platinum based chemotherapeutic agents and aminoglycosides are widely used and thus further evidence to clearly support or demonstrate a positive trend is needed to allow for widespread acceptance of antioxidant use with administration of these potentially deleterious drugs.
Conclusion
The role of antioxidants in the management of agerelated, noise-induced and drug-induced hearing loss continues to evolve and be elucidated. Studies published in the last several years have yielded promising results and are strongly suggestive of a protective role for these compounds. These studies have been largely limited to animal models and the research focus clearly needs to shift to more randomized, placebo-controlled, doubleblinded studies in humans. Nevertheless, results from an overwhelming majority of studies on antioxidants and acquired hearing loss demonstrate the beneficial effects of these compounds at a cellular and subcellular level, as well as in objective measures of hearing sensitivity, such as ABR testing. Two recent studies presented at the Combined Otolaryngology Sections Meeting (COSM) in San Diego (April 2007) highlight the continued research efforts in the field of antioxidant therapy. A study directed by Kopke et al. [43] investigated the role of oral NAC administration given during weapons training in the Marine Corps; 566 subjects were enrolled in the study, of which 289 were given placebo and 277 given NAC. The subjects received 900 mg/day of NAC or placebo for 16 days. Hearing status was evaluated prior to and 10 days following the 16-day weapons training, using pure-tone audiometry and DPOAEs. The results demonstrated a significant effect of NAC in reducing the significant threshold shift in ears exposed to more intense acoustic trauma at the dose used. The conclusion was that oral NAC was safe and effective [43] . Another study presented by Choi et al. [44] looked at the effectiveness of combinations of antioxidant compounds in the treatment of acute acoustic trauma. In the study, three groups of chinchillas (six per group) were exposed to 105 dB narrow-band noise centered at 4 kHz for 6 h. These groups were administered different antioxidant compound combinations and at different doses. The antioxidants studies were NAC, ALCAR and hydroxylated a-phenyl-tert-butylnitrone (4-OH-PBN). The results demonstrated that the chinchillas administered the two types of drug combinations and at different doses had their permanent threshold shifts completely eliminated as opposed to the chinchillas given a control carrier solution [44] . These results support the judicious use of antioxidants in individualized cases of acquired hearing loss. The medical practitioners' understanding of the literature regarding antioxidant use in hearing loss and recognition of the risks, benefits and alternatives of this type of therapy is paramount to appropriate management and counseling of patients.
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